Novel aminopyridones inhibit HIV reverse transcriptase, and are useful in the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, anti-infectives, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.
The reactions of nitrile oxides with S,S-dimethyl-N-(2,4,6-trihalophenyl)sulfimides gave unusual products, which structure was determined to be 2-aryl-4,6-dihalobenzoxazoles from their elementary analyses and spectral data. While the reactions with S,S-dimethyl-N-(2-bromophenyl)- or S,S-dimethyl-N-(2,4-dibromophenyl)sulfimide gave 1,2,4-benzoxadiazine derivatives. A plausible reaction mechanism for
The combination of certain aminopyridones and anti-HIV nucleoside analogs has been found to synergistically inhibit HIV reverse transcriptase. This combination is useful in the prevention or treatment of infection by HIV and the treatment of AIDS, either as a combination of compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in further combination with other antivirals, anti-infectives, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.
Incubation of 3-[(4,7-dichlorobenzoxazol-2-yl)methyl]amino-5-ethyl-6-methyl-2-(1H)-pyrid inone ##STR1## with a preparation from mammalian organ yields as biotransformation products the 5-(1-hydroxy)ethyl and 6-hydroxymethyl analogs. These products are useful in the prevention or treatment of infection by HIV and the treatment of AIDS.
2-Pyridinone derivatives: a new class of nonnucleoside, HIV-1-specific reverse transcriptase inhibitors
作者:Walfred S. Saari、Jacob M. Hoffman、John S. Wai、Thorsten E. Fisher、Clarence S. Rooney、Anthony M. Smith、Craig M. Thomas、Mark E. Goldman、Julie A. O'Brien